Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 2011-2020 of 2400 for

Edit search filters
  1. Ado-trastuzumab emtansine (T-DM1)-Induced Peripheral Neuropathy in HER2-positive Breast Cancer Patients

    Rochester, MN

  2. Cholangiocarcinoma Liquid Biopsy Monitoring for Treatment Response and Prognostic Outcomes

    Rochester, MN

  3. A Study to Evaluate Chemotherapy-Induced Nausea in Breast Cancer Patients

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN, Albert Lea, MN, Mankato, MN

  4. Analysis Of Live Tumor Fragments Of Surgical Resections

    Jacksonville, FL

  5. Tools to evaluate treatment tolerability in older patients with sarcoma

    Rochester, MN

  6. Mindfulness-Based Intervention (Muse-S™) as an Adjunct During Diagnostic Work-up in Patients Presenting to the Undiagnosed Mass Clinic (UMC).

    Scottsdale/Phoenix, AZ, Rochester, MN

  7. Predicting Responsiveness in Oncology Patients Based on Host Response Evaluation During Anti Cancer Treatments

    Jacksonville, FL

  8. Metabolite Levels in Ovarian Cancer Patients Receiving Maintenance PARP Inhibitors

    Rochester, MN

  9. A Study to Evaluate the Use of Organoids to Advance Precision Medicine in Bladder Cancer

    Rochester, MN

  10. Preclinical drug testing and assay development for lung adenocarcinoma characterized by the expression of ASCL1

    Rochester, MN

.

Mayo Clinic Footer